- Home
- SHOT vs CALC Comparison
SHOT vs CALC Comparison
Compare SHOT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- CALC
- Stock Information
- Founded
- SHOT 2018
- CALC 2011
- Country
- SHOT United States
- CALC United States
- Employees
- SHOT N/A
- CALC N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- CALC Health Care
- Exchange
- SHOT Nasdaq
- CALC Nasdaq
- Market Cap
- SHOT 30.4M
- CALC 26.7M
- IPO Year
- SHOT 2020
- CALC N/A
- Fundamental
- Price
- SHOT $0.31
- CALC $1.67
- Analyst Decision
- SHOT
- CALC Strong Buy
- Analyst Count
- SHOT 0
- CALC 3
- Target Price
- SHOT N/A
- CALC $16.33
- AVG Volume (30 Days)
- SHOT 7.1M
- CALC 16.3K
- Earning Date
- SHOT 08-13-2025
- CALC 08-11-2025
- Dividend Yield
- SHOT N/A
- CALC N/A
- EPS Growth
- SHOT N/A
- CALC N/A
- EPS
- SHOT N/A
- CALC N/A
- Revenue
- SHOT $573,336.00
- CALC N/A
- Revenue This Year
- SHOT N/A
- CALC N/A
- Revenue Next Year
- SHOT N/A
- CALC N/A
- P/E Ratio
- SHOT N/A
- CALC N/A
- Revenue Growth
- SHOT 69.32
- CALC N/A
- 52 Week Low
- SHOT $0.23
- CALC $1.43
- 52 Week High
- SHOT $1.77
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- SHOT 47.00
- CALC 45.93
- Support Level
- SHOT $0.23
- CALC $1.68
- Resistance Level
- SHOT $0.37
- CALC $1.79
- Average True Range (ATR)
- SHOT 0.05
- CALC 0.08
- MACD
- SHOT 0.01
- CALC -0.00
- Stochastic Oscillator
- SHOT 40.84
- CALC 34.48
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.